s6y
Company name or ticker
Search
Agharkar Shreeram
3
Relmada Therapeutics, Inc.: Initial statement of insider ownership
Filed
Friday, January 16, 2015
Period
Jan 6, 2015
Accession number
0001213900-15-000385
Documents
Ownership Document
3
On sec.gov
Filing index
All files
Complete submission text
SGML header